Syndax Pharmaceuticals: Down But Not Out
Syndax has a strong cash position and a significant market opportunity with Revuforj and Niktimvo. Check out my ...
News-Medical.Net on MSN5d
New drug target identified for treating acute myeloid leukemia
A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...
CURE6d
First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...
HLA-DRB1 molecule offers potential target for CAR therapy in relapsed acute myeloid leukemia post-transplantation
One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...
News-Medical.Net on MSN5d
HLA-DRB1 molecule can be a potential target in treating acute myeloid leukemia
In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...
Technology Networks6d
Novel Drug Target for Acute Myeloid Leukemia Identified
Scientists have identified a promising new drug target for acute myeloid leukemia, a deadly blood cancer with a five-year ...
Targeted Oncology6d
AlloHeme Enhances Early Relapse Detection in AML and MDS Post-Transplant
Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...
Rare blood cancer now detectable using a CRISPR-based test
RAPID-CRISPR test quickly and accurately diagnoses acute promyelocytic leukemia, a rare and aggressive blood cancer, with ...
Senti Bio Joins Webull Corporate Connect Service Platform
Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for ...